ADVANCELL ADVANCED IN VITRO CELL TECHNOLOGIES

Advanced In Vitro Cell Technologies S.L., a biotech nanomedicine company, engages in the development of drugs through the search for new applications for already-known molecules, and services and reagents. It also develops and markets in vitro cell models with a regulatory and/or predictive value. In addition, the company offers research services; safety assessment of cosmetic raw materials and finished products; vitro services for toxicological evaluation and advising; integrated and customized... research for absorption, distribution, metabolism, and elimination; skin biology and cosmetics; anti-tumoural activity of compounds; anti-inflammatory activity of new compounds and cell responses to inflammatory stimuli; biocompatibility for evaluating biocompatible materials; CacoReady system, an integral tool designed to optimize time and costs for intestinal absorption evaluation of compounds; CacoGoblet cell model that combines the absorbent qualities of Caco2 cells with a mucosecreting cell line; TransportPlus, a ready-to-use system for in vitro comparative absorption profiling; AdipoReady kit, an in vitro model for studying the toxicity of metabolites derived from the action of cytochrome P-450 isoenzymes in a ready-to-use system; and liver, lung, and human skin microsomes. Advanced In Vitro Cell Technologies S.L. was founded in 2001 and is based in Barcelona, Spain.
ADVANCELL ADVANCED IN VITRO CELL TECHNOLOGIES
Industry:
Biotechnology Health Care Nanotechnology
Founded:
2001-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.advancell.net
Total Employee:
11+
Status:
Active
Contact:
34 93 403 45 45
Email Addresses:
[email protected]
Total Funding:
11 M EUR
Technology used in webpage:
Bodis Australian Server Location Sedo Hosting
Similar Organizations
Avacta Animal Health
Avacta Animal Health is an veterinary laboratory service provider and diagnostic tester to surgeons, laboratories on animal allergies.
BIND Therapeutics
BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Mantis Deposition
Mantis Deposition is a specialty instrumentation company developing deposition components and systems for the thin film coating community.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Current Employees Featured
Investors List
Talde Private Equity
Talde Private Equity investment in Venture Round - Advancell Advanced In Vitro Cell Technologies
Official Site Inspections
http://www.advancell.net
- Host name: lb-182-253.above.com
- IP address: 103.224.182.253
- Location: Australia
- Latitude: -33.494
- Longitude: 143.2104
- Timezone: Australia/Sydney

More informations about "Advancell Advanced In Vitro Cell Technologies"
Advancell Advanced In Vitro Cell Technologies
Contact Email [email protected] Phone Number 34 93 403 45 45 Advanced In Vitro Cell Technologies S.L., a biotech nanomedicine company, engages in the development of drugs through the search for new …See details»
AdvanCell Company Profile 2025: Valuation, Funding & Investors
AdvanCell General Information Description. Operator of a radiopharmaceutical company intended for developing alpha therapies for cancer patients. The company develops alpha-emitting …See details»
About - Advancell
We are proud to offer Advancell from SEKISUI Specialty Chemicals (SSC), part of the multibillion-dollar, multinational company SEKISUI CHEMICAL Group.SSC is one of 11 SEKISUI America Corporation subsidiaries and one …See details»
AdvanCell - Crunchbase Company Profile & Funding
Organization. AdvanCell . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed …See details»
Organization | Advancell - Advanced In Vitro Cell Technologies, S.A.
Advancell - Advanced In Vitro Cell Technologies, S.A. Report issue. For profit Phase 2. Founded: Barcelona Spain ... Organization Overview. First Clinical Trial. 2007 NCT00559624. First …See details»
Advancell - Scientist.com
Advancell.net: Headquarters: Barcelona, Catalunya, ES Company Type: Small Business (1-10M TTM Revenue) Description Sites Advancell offers animal models, drug delivery, BA/BE …See details»
AdvanCell - Company Profile - Tracxn
Dec 22, 2024 AdvanCell. has raised a total funding of $17.4M over 2 rounds. Its first funding round was on Aug 24, 2022. List of recent funding rounds of AdvanCell. Date of funding. …See details»
Advancell - Overview, News & Similar companies | ZoomInfo.com
Advancell contact info: Phone number: +34 934034545 Website: www.advancell.net What does Advancell do? ADVANCELL focuses on indications with a clear unmet medical need in …See details»
Advancell - Products, Competitors, Financials, Employees, …
About Advancell. Advancell focuses on in vitro cell technologies in the pharmaceutical research sector. The company provides research products and services that assist in drug development …See details»
AdvanCell - LinkedIn
AdvanCell | 3,175 followers on LinkedIn. Changing the Course of Cancer Treatment | AdvanCell is a clinical stage radiopharmaceutical company developing an innovative pipeline of 212Pb …See details»
AdvanCell - Funding, Financials, Valuation & Investors - Crunchbase
AdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment. Search Crunchbase. ... How much funding has …See details»
ADVANCELL PTY LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ADVANCELL PTY LIMITED of Sydney, NEW SOUTH WALES. Get the latest business insights from Dun & …See details»
Advancell – Innovative thermo-expandable microspheres for a …
Advancell product molecules incorporate various structural characteristics based on innovative technology cultivated by Sekisui Chemical. By applying multilayer particle technology and …See details»
Bringing Targeted Alpha - AdvanCell
About AdvanCell. AdvanCell is a radiopharmaceutical company that works with technology to develop a revolutionary cancer treatment called Targeted Alpha Therapy, providing new hope …See details»
AdvanCell Announces the Launch of its Flagship Facility to Support ...
AdvanCell is a radiopharmaceutical company developing an innovative pipeline of 212Pb-based Targeted Alpha Therapies for cancer patients. AdvanCell’s platform technology addresses the …See details»
Advancell (Drug Delivery) - PitchBook
Mar 12, 2007 Is Advancell (Drug Delivery) a private or public company? Advancell (Drug Delivery) is a Private company. What is Advancell (Drug Delivery)’s current revenue? The …See details»
ADVANCELL - Pharmaceutical Business review
Based on the properties of its technology, ADVANCELL’s nanosystems are suitable for formulating small molecule drugs, proteins, peptides, antibodies or antibody fragments and …See details»
AdvanCell Commences Drug Product Manufacture from its Facility …
AdvanCell Pty Ltd ACN 633 959 010 Level 7 Macquarie House 167 Macquarie Street Sydney NSW 2000 Australia [email protected] T +61 2 8000 4199 F +61 2 8000 4198 …See details»
AdvanCell
AdvanCell is a vertically integrated, clinical stage radiopharmaceutical company developing novel targeted alpha therapies to improve survival and the quality of life for patients with cancer. …See details»
News - AdvanCell
Andrew is a founder and Managing Director of AdvanCell Isotopes, and a founder and Director of Riverland Capital, a private investment firm. Read more. JULIAN KELLY. Chief Nuclear …See details»